S. HÜLAGÜ, "Utilizing daily interferon alpha 2b and ribavirin combination therapy in chronic hepatitis C a preliminary report," J Okla State Med Assoc , vol.92, pp.573-577, 1999
HÜLAGÜ, S. 1999. Utilizing daily interferon alpha 2b and ribavirin combination therapy in chronic hepatitis C a preliminary report. J Okla State Med Assoc , vol.92 , 573-577.
HÜLAGÜ, S., (1999). Utilizing daily interferon alpha 2b and ribavirin combination therapy in chronic hepatitis C a preliminary report. J Okla State Med Assoc , vol.92, 573-577.
HÜLAGÜ, SADETTİN. "Utilizing daily interferon alpha 2b and ribavirin combination therapy in chronic hepatitis C a preliminary report," J Okla State Med Assoc , vol.92, 573-577, 1999
HÜLAGÜ, SADETTİN. "Utilizing daily interferon alpha 2b and ribavirin combination therapy in chronic hepatitis C a preliminary report." J Okla State Med Assoc , vol.92, pp.573-577, 1999
HÜLAGÜ, S. (1999) . "Utilizing daily interferon alpha 2b and ribavirin combination therapy in chronic hepatitis C a preliminary report." J Okla State Med Assoc , vol.92, pp.573-577.
@article{article, author={SADETTİN HÜLAGÜ}, title={Utilizing daily interferon alpha 2b and ribavirin combination therapy in chronic hepatitis C a preliminary report}, journal={J Okla State Med Assoc}, year=1999, pages={573-577} }